These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 29114116)

  • 41. Clinicians' perceptions of the quality of outsourced radiology and actions taken around perceived imaging errors in practice.
    Graham Y; Hayes C; Mehrotra P; Spratt J; Siddle K; Cox J
    Eur Radiol; 2019 Apr; 29(4):1649-1654. PubMed ID: 30542751
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Factors influencing decision making for healthcare services outsourcing: A review and Delphi study.
    Kavosi Z; Rahimi H; Khanian S; Farhadi P; Kharazmi E
    Med J Islam Repub Iran; 2018; 32():56. PubMed ID: 30175082
    [No Abstract]   [Full Text] [Related]  

  • 43. Outsourcing and benchmarking in a rural public hospital: does economic theory provide the complete answer?
    Young SH
    Rural Remote Health; 2003; 3(1):124. PubMed ID: 15877485
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Improving academic leadership and oversight in large industry-sponsored clinical trials: the ARO-CRO model.
    Goldenberg NA; Spyropoulos AC; Halperin JL; Kessler CM; Schulman S; Turpie AG; Skene AM; Cutler NR; Hiatt WR;
    Blood; 2011 Feb; 117(7):2089-92. PubMed ID: 21068436
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Using clinical reasoning ontologies to make smarter clinical decision support systems: a systematic review and data synthesis.
    Dissanayake PI; Colicchio TK; Cimino JJ
    J Am Med Inform Assoc; 2020 Jan; 27(1):159-174. PubMed ID: 31592534
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The nature of outsourced preclinical research--the example of chemical synthesis.
    Festel GW
    Expert Opin Drug Discov; 2013 Sep; 8(9):1049-55. PubMed ID: 23725522
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Developing decision model for the outsourcing of medical service delivery in the public hospitals.
    Khosravizadeh O; Maleki A; Ahadinezhad B; Shahsavari S; Amerzadeh M; Tazekand NM
    BMC Health Serv Res; 2022 Feb; 22(1):135. PubMed ID: 35101040
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Production of high-quality marketing applications: strategies for biotechnology companies working with contract research organizations.
    Hecker SJ; Preston C; Foote M
    Biotechnol Annu Rev; 2003; 9():269-77. PubMed ID: 14650931
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Biopharma CRO industry in China: landscape and opportunities.
    Xia C; Gautam A
    Drug Discov Today; 2015 Jul; 20(7):794-8. PubMed ID: 25701282
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Concerns and hopes about outsourcing decisions regarding health information management services at two teaching hospitals in Semnan, Iran.
    Kahouei M; Farrokhi M; Abadi ZN; Karimi A
    Health Inf Manag; 2016 Apr; 45(1):36-44. PubMed ID: 28691564
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Bioanalytical method transfer considerations of chromatographic-based assays.
    Williard CV
    Bioanalysis; 2016 Jul; 8(13):1409-13. PubMed ID: 27277876
    [TBL] [Abstract][Full Text] [Related]  

  • 52. New, strategic outsourcing models to meet changing clinical development needs.
    Jones J; Minor M
    Perspect Clin Res; 2010 Apr; 1(2):76-9. PubMed ID: 21829788
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Avoiding and identifying errors in health technology assessment models: qualitative study and methodological review.
    Chilcott J; Tappenden P; Rawdin A; Johnson M; Kaltenthaler E; Paisley S; Papaioannou D; Shippam A
    Health Technol Assess; 2010 May; 14(25):iii-iv, ix-xii, 1-107. PubMed ID: 20501062
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Bioanalytical outsourcing: transitioning from Pharma to CRO.
    Hayes R
    Bioanalysis; 2017 Aug; 9(15):1149-1152. PubMed ID: 28763257
    [No Abstract]   [Full Text] [Related]  

  • 55. Assessing uncertainty in outsourcing clinical services at tertiary health centers.
    Billi JE; Pai CW; Spahlinger DA
    Int J Health Plann Manage; 2007; 22(3):245-53. PubMed ID: 17624877
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Outsourcing in public health: a case study of contract failure and its aftermath.
    Young S
    J Health Organ Manag; 2008; 22(5):446-64. PubMed ID: 18959298
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Unfulfilled translation opportunities in industry sponsored clinical trials.
    Smed M; Getz KA
    Contemp Clin Trials; 2013 May; 35(1):80-6. PubMed ID: 23454567
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Efficient interactions with bioanalytical contract research organizations: inside scoop.
    Tan A; Fanaras C; Fanaras JC
    Bioanalysis; 2022 Aug; 14(16):1081-1084. PubMed ID: 36194671
    [No Abstract]   [Full Text] [Related]  

  • 59. A qualitative systematic review of internal and external influences on shared decision-making in all health care settings.
    Truglio-Londrigan M; Slyer JT; Singleton JK; Worral P
    JBI Libr Syst Rev; 2012; 10(58):4633-4646. PubMed ID: 27820528
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Biotech outsourcing strategies cmc--biologics stream. June 17, 2010, Copenhagen, Denmark.
    Hamer K
    MAbs; 2010; 2(5):461-5. PubMed ID: 20716956
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.